Other Events ·
Clearmind Medicine Inc. issued a press release on July 10, 2026, regarding its response to a U.S. Administration…
CMNDClearmind Medicine Inc.
Clearmind Medicine Inc. issued a press release on July 10, 2026, regarding its response to a U.S. Administration Request for Information (RFI) concerning addiction treatment innovations under the Great American Recovery Initiative. The company is participating in this regulatory feedback process to address addiction treatment needs. Clearmind Medicine is a biopharmaceutical company focused on developing novel treatments for mental health disorders.